Prostate Cancer
Conditions
Interventions
Case series:Neoadjuvant therapy
Sponsors
Urology Department, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
Male
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 45 to 75 years old; 2. good organ function and can metabolize the imaging agent normally; 3. life expectancy >=10 years; 4. no contraindications for radical prostatectomy + expanded lymphadenectomy; 5. Subjects signed an informed consent form prior to enrollment, indicating that they agreed to participate in the study and followed the study procedures
Exclusion criteria
Exclusion criteria: 1. History of other malignant tumors; uncontrolled systemic infection; 2. previous history of imaging agent drug allergies and adverse reactions; 3. vital organs in patients with acute disease progression and parasitic diseases; 4. human immunodeficiency virus (HIV) positive patients, immunodeficiency Patients with sexual diseases, combined immunodeficiency diseases, organ transplants, patients with autoimmune diseases requiring immunosuppressive drugs or steroids, or other severe immunosuppressive states; 5. any mental or cognitive disorders, emotional instability, may restrict understanding, execution, and compliance with the study; 6. other circumstances that the investigator believes are not suitable for participating in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PSA;PI-RADS score;tumor volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recist score;TNM stage;pathologic complete response; | — |
Countries
China
Contacts
Public ContactJiahua Pan
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Outcome results
None listed